Improved treatment targeting root cause of cystic fibrosis may be on horizon

A clinical trial led by a pharmaceutical company with additional support from an NIDDK-supported Cystic Fibrosis Center has shown that a combination of two medications provides significant clinical benefit in a subgroup of patients with cystic fibrosis (CF).
Source: NIDDK News - Category: Endocrinology Source Type: news